Hydroxy acids and derivatives
Medchemexpress LLC Varenicline tartrate | 375815-87-5 | MFCD08460603 | 100.0% | 361.127 Da | C17H19N3O6 | 25 MG
Varenicline tartrate is the tartrate salt of varenicline supplied as an analytical research standard for studies of nicotinic acetylcholine receptor pharmacology and nicotine dependence. It is an orally active partial agonist at α4β2 nicotinic acetylcholine receptors, provided as a high-purity solid suitable for analytical and pharmacological applications.
- High purity suitable for analytical use.
- Solid form for easy handling and storage.
- Suitable for receptor pharmacology and nicotine dependence studies.
- Provided as an analytical standard for quantitative assays.
- Available in 25 mg pack sizes for small-scale research.
Medchemexpress LLC 2-Hydroxybutyric acid | 600-15-7 | 98.0% | 104.10 | 50 MG
2-Hydroxybutyric acid (α-Hydroxybutyric acid) is converted from 2-Aminobutyric acid, with 2-oxobutyric acid as an intermediate metabolite. It is a potential biomarker for type 2 diabetes and preeclampsia. It also prevents acetaminophen (AP)-induced liver injury.
- Potential biomarker for type 2 diabetes
- Potential biomarker for preeclampsia
- Prevents acetaminophen (AP)-induced liver injury
Apexbio Technology LLC Lasofoxifene (tartrate) 190791-29-8 25mg
Lasofoxifene tartrate (CAS 190791-29-8) is a small-molecule selective estrogen receptor modulator (SERM) targeting estrogen receptor-alpha (ER- ) and acting as a selective inverse agonist at the cannabinoid receptor subtype CB2 It is designed to modulate estrogen receptor signaling in a tissue-dependent manner thereby regulating estrogen-related biological pathways Lasofoxifene tartrate exerts its biological activity through dual estrogen agonist antagonist actions depending on tissue context In preclinical studies using ovariectomized rat models Lasofoxifene tartrate prevents estrogen deficiency-associated bone loss reduces serum cholesterol and body mass without inducing uterine hypertrophy Based on these pharmacological properties Lasofoxifene tartrate holds research potential in the management of osteoporosis breast cancer and cardiovascular health in postmenopausal women
Medchemexpress LLC Ifenprodil tartrate | 23210-58-4 | 99.9% | 1 ML
Ifenprodil tartrate is a cerebral vasodilator and a noncompetitive NMDA receptor antagonist, with high affinity for NR1A/NR2B receptors. It also acts as an α1 adrenergic receptor antagonist and inhibits GIRK (Kir3) activity. This compound shows inhibitory effects against A/H1N1 strains and offers neuroprotective, anticonvulsant, and antinociceptive properties, making it valuable for research into cerebrovascular diseases and peripheral arterial obliterative disease. This product is supplied as a 10 mM solution in 1 mL.
- Cerebral vasodilator
- Noncompetitive NMDA receptor antagonist
- High affinity for NR1A/NR2B receptors
- Acts as an α1 adrenergic receptor antagonist
- Inhibits GIRK (Kir3)
- Inhibits A/H1N1 strains
- Neuroprotective, anticonvulsant, and antinociceptive
- Used in cerebrovascular and peripheral arterial disease research
Apexbio Technology LLC Rivastigmine Tartrate 129101-54-8 50mg
Rivastigmine tartrate (CAS 129101-54-8) is a reversible inhibitor of both acetylcholinesterase and butyrylcholinesterase enzymes responsible for the hydrolysis of acetylcholine in the central nervous system By inhibiting these enzymes rivastigmine enhances cholinergic neurotransmission and increases synaptic acetylcholine availability This compound is widely utilized in studies related to cholinergic dysfunction including models of mild to moderate Alzheimer s disease and Parkinson s disease-associated dementia providing a tool for investigating cholinergic signaling pathways and potential therapeutic interventions in neurodegenerative disorders
Medchemexpress LLC L-glyceric acid sodium | 146298-95-5 | MFCD28363841 | 99.0% | 128.06 g/mol | C3H5NaO4 | 5 MG
L-glyceric acid sodium is the sodium salt of L-glyceric acid, a urinary metabolite that accumulates in L-glyceric aciduria. Supplied as a high-purity analytical reference standard, it is intended for metabolic research and diagnostic applications requiring accurate reference material. The compound has formula C3H5NaO4, molecular weight 128.06 g/mol, and reported purity 99.0%.
- Purity of 99.0%.
- Molecular weight 128.06 g/mol.
- Chemical formula C3H5NaO4.
- Available in small milligram pack sizes for analytical use.
- Intended as an analytical reference for metabolic and diagnostic studies involving L-glyceric aciduria.
Apexbio Technology LLC Ketanserin tartrate 83846-83-7 100mg
Ketanserin tartrate (CAS 83846-83-7) is a selective antagonist of 5-HT2 receptors Experimental studies have demonstrated that it inhibits hERG potassium currents in a concentration-dependent manner exhibiting an IC50 of 0 11 M Due to its defined receptor selectivity and electrophysiological properties Ketanserin tartrate is widely employed in pharmacological studies and in research focused on cardiovascular system disorders
Medchemexpress LLC LY2940094 tartrate 50mg | 1307245-87-9 | 50 MG
LY2940094 tartrate is the tartrate salt of LY2940094, a potent, brain-penetrant nociceptin (NOP) receptor antagonist supplied as a solid for research use.
- Supplied as a 50 mg solid powder.
- High purity suitable for in vitro and preclinical studies.
- Molecular weight 631.05 g/mol and formula C26H29ClF2N4O8S.
- Store sealed at 4°C; in solution store at -80°C for long-term storage.
- Provided with a batch-specific certificate of analysis.
Medchemexpress LLC 2-Hydroxyhexanoic acid | 6064-63-7 | MFCD00004584 | 99.95% | C6H12O3 | 5 G
2-Hydroxyhexanoic acid is a metabolite that is elevated in metastatic pancreatic neuroendocrine tumors. It does not promote the proliferation, migration, or invasion of pancreatic neuroendocrine tumor cells and can be used in the research of metastatic pancreatic neuroendocrine tumors.
- Metabolite elevated in metastatic pancreatic neuroendocrine tumors
- Does not promote proliferation, migration, or invasion of pancreatic neuroendocrine tumor cells
- Useful for research related to metastatic pancreatic neuroendocrine tumors
- Target: Human endogenous metabolite
Medchemexpress LLC 2-Hydroxyhexanoic acid | 6064-63-7 | 99.95% | C6H12O3 | 1 G
2-Hydroxyhexanoic acid is a metabolite elevated in metastatic pancreatic neuroendocrine tumors. It does not promote the proliferation, migration, or invasion of pancreatic neuroendocrine tumor cells, making it suitable for research into metastatic pancreatic neuroendocrine tumors.
- Elevated in metastatic pancreatic neuroendocrine tumors
- Does not promote proliferation, migration, or invasion of pancreatic neuroendocrine tumor cells
- Useful in research of metastatic pancreatic neuroendocrine tumors
- Classified as an endogenous metabolite
- Part of the ketones, aldehydes, acids structure classification